AUPH Competitors & Alternatives
Compare Aurinia Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AUPH
Main Stock$16.65
Tradestie Score
40
Market Cap
$1.50B
P/E Ratio
7.6
Revenue Growth
0.2%
Analyst Upside
+9.1%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.08
|
$2.37B | 120.7 | 58 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$134.75
|
$2.35B | - | 56 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.79
|
$2.34B | - | 43 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$79.81
|
$2.33B | - | 50 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$33.09
|
$2.33B | - | 56 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 46 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.50
|
$2.23B | - | 42 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$65.71
|
$2.21B | - | 36 | Compare |
More AUPH Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry